DE69631158D1 - Verbindungen und deren verwendung zur behandlung von infektiösen erkrankungen - Google Patents

Verbindungen und deren verwendung zur behandlung von infektiösen erkrankungen

Info

Publication number
DE69631158D1
DE69631158D1 DE69631158T DE69631158T DE69631158D1 DE 69631158 D1 DE69631158 D1 DE 69631158D1 DE 69631158 T DE69631158 T DE 69631158T DE 69631158 T DE69631158 T DE 69631158T DE 69631158 D1 DE69631158 D1 DE 69631158D1
Authority
DE
Germany
Prior art keywords
compounds
infectious diseases
treating infectious
salts
image
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69631158T
Other languages
English (en)
Other versions
DE69631158T2 (de
Inventor
I Bukrinsky
Anthony Cerami
Peter Ulrich
J Berger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PICOWER INST FOR MEDICAL RES M
Original Assignee
PICOWER INST FOR MEDICAL RES M
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/369,830 external-priority patent/US5574040A/en
Application filed by PICOWER INST FOR MEDICAL RES M filed Critical PICOWER INST FOR MEDICAL RES M
Publication of DE69631158D1 publication Critical patent/DE69631158D1/de
Application granted granted Critical
Publication of DE69631158T2 publication Critical patent/DE69631158T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/16—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/24—Y being a hetero atom
    • C07C279/26—X and Y being nitrogen atoms, i.e. biguanides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40—Nitrogen atoms
    • C07D251/48—Two nitrogen atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE69631158T 1995-01-06 1996-01-05 Verbindungen und deren verwendung zur behandlung von infektiösen erkrankungen Expired - Fee Related DE69631158T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US369830 1995-01-06
US08/369,830 US5574040A (en) 1995-01-06 1995-01-06 Pyrimidine compounds and methods of use to derivatize neighboring lysine residues in proteins under physiologic conditions
US08/463,405 US5733932A (en) 1995-01-06 1995-06-05 Compounds and methods of use to derivatize neighboring lysine residues in proteins under physiological conditions
US463405 1995-06-05
PCT/US1996/000486 WO1996020932A1 (en) 1995-01-06 1996-01-05 Compounds and methods of use to treat infectious diseases

Publications (2)

Publication Number Publication Date
DE69631158D1 true DE69631158D1 (de) 2004-01-29
DE69631158T2 DE69631158T2 (de) 2004-08-26

Family

ID=27004718

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69631158T Expired - Fee Related DE69631158T2 (de) 1995-01-06 1996-01-05 Verbindungen und deren verwendung zur behandlung von infektiösen erkrankungen

Country Status (7)

Country Link
US (4) US5733932A (de)
EP (1) EP0865434B1 (de)
AT (1) ATE256667T1 (de)
AU (1) AU715844B2 (de)
CA (1) CA2218561C (de)
DE (1) DE69631158T2 (de)
WO (1) WO1996020932A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9224739D0 (en) * 1992-11-26 1993-01-13 Wellcome Found Medicaments
US6297253B1 (en) * 1996-10-15 2001-10-02 The Picower Institute For Medical Research Compounds and methods of use to treat infectious diseases
AU2960000A (en) * 1999-01-08 2000-07-24 University Of Massachusetts Detection of human immunodeficiency virus
US6734192B1 (en) * 1999-08-23 2004-05-11 Mp-1 Inc. Treatment of viral infections
ES2154604B1 (es) * 1999-09-06 2001-11-16 Gonzalez Regueral Valdes Jose Medicacion de uso topico aplicable para el tratamiento de enfermedades producidas por virus, especialmente el herpes simplex de los tipos h sv1 y hsv2
US6906067B2 (en) * 1999-12-28 2005-06-14 Bristol-Myers Squibb Company N-heterocyclic inhibitors of TNF-α expression
JP2003519143A (ja) * 1999-12-28 2003-06-17 ファーマコピーア，インコーポレーティッド ピリミジン及びトリアジン系キナーゼ阻害剤
US7081470B2 (en) * 2001-01-31 2006-07-25 H. Lundbeck A/S Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
US20040127502A1 (en) 2001-01-31 2004-07-01 Synaptic Pharmaceutical Corporation Use of GAL3 antagonist for treatment of depression
TWI329105B (en) 2002-02-01 2010-08-21 Rigel Pharmaceuticals Inc 2,4-pyrimidinediamine compounds and their uses
US6797464B2 (en) * 2002-07-10 2004-09-28 University Of Massachusetts Detection of drug-resistant human immunodeficiency virus
MXPA05001096A (es) * 2002-07-29 2005-11-23 Rigel Pharmaceuticals Inc Metodos para tratamiento o prevencion de enfermedades autoinmunes con compuestos de 2,4-diamino-pirimidina.
US20090018150A1 (en) * 2003-07-24 2009-01-15 Asterand Uk Limited 5-Ht2b Receptor Antagonists
KR20120062863A (ko) 2003-07-30 2012-06-14 리겔 파마슈티칼스, 인크. 자가면역 질환의 치료 또는 예방에 사용하기 위한 2,4-피리미딘디아민 화합물
CA2584295C (en) * 2004-11-24 2014-08-26 Rigel Pharmaceuticals, Inc. Spiro-2, 4-pyrimidinediamine compounds and their uses
WO2007027238A2 (en) * 2005-05-03 2007-03-08 Rigel Pharmaceuticals, Inc. Jak kinase inhibitors and their uses
WO2006130832A2 (en) * 2005-06-02 2006-12-07 The General Hospital Corporation Anti-infective and immunomodulatory compounds

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3908013A (en) * 1970-09-17 1975-09-23 Armour Pharma Pharmaceutical aromatic guanidine compositions and methods of using same
DE2144583A1 (de) * 1970-11-10 1972-05-18 Armour Pharmaceutical Co., Chicago, 111. (V.StA.) Pharmazeutisches Präparat und Verfahren zu seiner Anwendung
US4051256A (en) * 1976-09-19 1977-09-27 Imperial Chemical Industries Limited Guanidine derivatives
DK130584A (da) * 1983-04-08 1984-10-09 Ciba Geigy Ag N-(2-nitrophenyl)-4-amino-pyrimidin-derivater samt deres fremstilling og anvendelse som mikrobicider
GB8510758D0 (en) * 1985-04-27 1985-06-05 Wellcome Found Compounds
JPH0629263B2 (ja) * 1985-10-30 1994-04-20 クミアイ化学工業株式会社 ピリミジン誘導体および農園芸用殺菌剤
US5093525A (en) * 1986-07-10 1992-03-03 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University N,N'-disubstituted guanidines and their use as excitatory amino acid antagonists
US4782062A (en) * 1987-05-11 1988-11-01 Merck & Co., Inc. 9-(2-hydroxymethyl)cycloalkylmethyl) guanines
US4900813A (en) * 1987-07-02 1990-02-13 Ciba-Geigy Corporation Fiber-reactive azo dyes having a 4,6-diaminopyridine coupling component
PH27460A (en) * 1989-12-28 1993-07-09 Kumiai Chemical Industry Co Pyrimidine derivatives and herbicidal composition containing the same
GB9012592D0 (en) * 1990-06-06 1990-07-25 Smithkline Beecham Intercredit Compounds
DE4120247A1 (de) * 1991-06-19 1992-12-24 Henkel Kgaa Neue tetraaminopyrimidin-derivate und deren verwendung in oxidationsfaerbemitteln
US5599984A (en) * 1994-01-21 1997-02-04 The Picower Institute For Medical Research Guanylhydrazones and their use to treat inflammatory conditions

Also Published As

Publication number Publication date
US5620983A (en) 1997-04-15
US5840893A (en) 1998-11-24
EP0865434B1 (de) 2003-12-17
WO1996020932A1 (en) 1996-07-11
US5703086A (en) 1997-12-30
AU715844B2 (en) 2000-02-10
CA2218561A1 (en) 1996-07-11
DE69631158T2 (de) 2004-08-26
ATE256667T1 (de) 2004-01-15
CA2218561C (en) 2009-09-15
EP0865434A4 (de) 1998-09-23
US5733932A (en) 1998-03-31
EP0865434A1 (de) 1998-09-23
AU4755996A (en) 1996-07-24

Similar Documents

Publication Publication Date Title
DE69631158D1 (de) Verbindungen und deren verwendung zur behandlung von infektiösen erkrankungen
ATE220400T1 (de) Trizyklische verbindungen zur behandlung von zellproliferativen störungen
DE69113155T2 (de) 17-beta-substituierte-4-aza-5-alpha-androstan-3-one-derivate und verfahren zu ihrer herstellung.
DE69528273D1 (de) 1,2-substituierte imidazolylverbindungen zur behandlung von entzündungen
ATE264846T1 (de) Substituierte benzimidazol-derivaten und ihre verwendung zur behandlung retroviraler infektionen
DE69628556D1 (de) Tricyclische verbindungen als inhibitoren von farnesyl protein transferase
FI913478A0 (fi) Diazinderivat.
FI943838A0 (fi) Vinyleeniatsaindolijohdannaiset ja menetelmä niiden valmistamiseksi
DE59409312D1 (de) Imidazopyridine und ihre anwendung zur behandlung von magen-darm krankheiten
ES2153851T3 (es) Tratamiento de la atrofia de la piel y de la vagina.
EA200001133A1 (ru) Антипикорнавирусные композиции, их получение и применение
ES2123652T3 (es) 7-(2-aminoetil)-benzotiazolonas.
DE69632876D1 (de) 2-Amino-Benzoxazinone zur Behandlung von viralen Infektionen
DE69610628T2 (de) N-(2,4-Dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3-yl)-3-amide
DE69127976T2 (de) Tropolonderivate und pharmazeutische zubereitungen davon zur vorbeugung und behandlung von ischämischen krankheiten
ES2194102T3 (es) Nuevas n-(2,4-dioxo-2,3,4,5-tetrahidro-1h-1,5-benzodiazepin-3-il)-3-amidas.
DE69307674D1 (de) HIV-Proteaseinhibitoren und ihre Verwendung zur Behandlung von AIDS
ATE157660T1 (de) Hydroxymethylfurazancarbonsäurederivate und ihre verwendung in der behandlung von kardiovaskulären erkrankungen
ES2137665T3 (es) Nuevos derivados de piridina o piridazina, procedimientos para su preparacion, y medicamentos que contienen estos compuestos.
DE68926222D1 (de) Verwendung von 1,2,3,4-Tetrahydroacridinen zur Behandlung von AIDS, sowie Verbindungen
DE69916103D1 (de) 3-alkoxylbenzylaminderivate und ihre verwendung als arzneimittel zur behandlung von schizophrenie
DE69429538D1 (de) Verwendung von 2-aminopurinderivaten zur behandlung und prophylaxe der menschlichen herpesvirus 6 infektionen
EA199800575A1 (ru) Производные пиперазина

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee